New patent expiration for Gilead drug EMTRIVA

Annual Drug Patent Expirations for EMTRIVA Emtriva is a drug marketed by Gilead and is included in two NDAs. It is available from two suppliers. There are two patents protecting…

The post New patent expiration for Gilead drug EMTRIVA appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.